论文部分内容阅读
探讨消癌平针剂对人胃癌 (SGC -790 1)细胞的抑制作用及其作用机理。采用人胃癌 (SGC -790 1)细胞的体内试验 (SRC法 )、体外试验、流式细胞仪检测法和形态学检查。结果 :消癌平针剂对人胃癌 (SGC -790 1)细胞有明显的抑制作用 ,流式细胞仪检测细胞主要停留在G1 期 ,形态学检查提示细胞呈现分化的趋势。提示消癌平针剂对人胃癌 (SGC -790 1)细胞的抑制作用靶点为细胞周期—G1 期
To investigate the inhibitory effect of Xiaoaiping injection on human gastric cancer (SGC-790 1) cells and its mechanism of action. In vivo tests (SRC method) of human gastric cancer (SGC-790 1) cells, in vitro tests, flow cytometry, and morphological examinations were performed. RESULTS: The Xiaoganping injection had obvious inhibitory effect on human gastric cancer (SGC-790 1) cells. Flow cytometry detected that the cells mainly stayed in G1 phase. Morphological examination suggested that the cells showed differentiation tendency. It is suggested that the inhibitory effect of Xiaomaiping injection on human gastric cancer (SGC-790 1) cells targets the cell cycle-G1 phase